Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chitodex + budesonide with or without ropivacaine after endoscopic sinus surgery
ACTRN12615000276550Phase 2Recruiting
- Sponsor
- University of Adelaide
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ropivacaine and budesonide in chronic rhinosinusitis (CRS) (2 arms), sponsored by University of Adelaide. Primary endpoint: Postoperative pain. Started Mar 2015; status: recruiting.
02
Drugs
ropivacainebudesonide
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on ACTRN12615000276550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000276550.